IFNG and neoplasm: Research indicates that TET2 plays a role in activating IFN-γ-induced chemokine and PD-L1 gene expression by mediating the IFN-γ/JAK2/STAT1 signaling pathway, thereby contributing to an immunosuppressive tumor microenvironment.